Glucocorticoids save lives in COVID-19 patients

Int J Biol Sci. 2020 Jul 7;16(13):2477-2478. doi: 10.7150/ijbs.49125. eCollection 2020.

Abstract

Recent studies showed that glucocorticoid drugs, which are easily available as pills on pharmacy shelves worldwide, could save lives of COVID-19 patients. With the swiftly increasing infections of the SARS-CoV-2 pandemic at a lethality rate of about 4.7% countless lives may be saved globally.

Keywords: COVID-19; Glucocorticoid.

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections*
  • Glucocorticoids*
  • Humans
  • Interleukin-6
  • Pandemics*
  • Peptidyl-Dipeptidase A*
  • Pneumonia, Viral*
  • SARS-CoV-2

Substances

  • Glucocorticoids
  • Interleukin-6
  • Peptidyl-Dipeptidase A